Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities
Net loss	$ (6,875,903)	$ (9,331,746)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	448,388	610,327
Loss on disposal of property and equipment	64,908	30,558
Noncash lease expense	420,411	293,506
Bad debt expense	(1,543)	(1,839)
Share-based compensation	66,577	72,417
Interest expense paid in equity shares	32,145	1,521,992
Accounts payable paid in equity shares	102,500
Accrued interest on notes payable	1,290,615	329,264
Amortization of original issue discounts on notes payable	883,467	583,333
Gain/(loss) on marketable securities	58	(159,905)
Discharge of Paycheck Protection Program Loans		(971,500)
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:
Trade receivables	(1,870,729)	1,572,113
Trade receivables - related party	(408,464)	14,641
Inventory	(73,209)	(1,396,073)
Prepaid expenses and other current assets	(166,756)	(708,456)
Other assets	(185,165)	(78,146)
Other liabilities	(231,998)	(17,163)
Accounts payable	256,584	432,372
Accounts payable - related party	(15,765)
Operating lease liabilities	(356,176)	(201,578)
Deposits from customers	1,618	(288,503)
Accrued expenses	791,618	(312,693)
Deferred revenue	481,457	722,975
Income taxes payable	(37,698)	(312,006)
Net cash used by operating activities - continuing operations	(5,383,060)	(7,596,110)
Net cash provided by operating activities - discontinued operations	2,488,144	133,512
Net cash used by operating activities	(2,894,916)	(7,462,598)
Cash Flows from Investing Activities
Purchase of property and equipment	(263,732)	(706,392)
Proceeds from sale of property and equipment	11,026	230,901
Investment in MasterpieceVR		(500,000)
Proceeds from sale of marketable securities		176,945
Purchase of marketable securities		(4,626,862)
Net cash used by investing activities - continuing operations	(252,706)	(5,425,408)
Net cash provided by investing activities - discontinued operations		(2,349)
Net cash used by investing activities	(252,706)	(5,427,757)
Cash Flows from Financing Activities
Proceeds from notes payable		8,000,000
Payments on notes payable	(544,370)	(901,763)
Payments on Paycheck Protection Program Loans	(10,033)
Payments on bank loans	(365,724)	(613,900)
Net cash (used)/provided by financing activities	(920,127)	6,484,337
Effect of currency translation	(126,593)	(150,076)
Net decrease in cash, cash equivalents, and restricted cash	(4,067,749)	(6,406,018)
Cash, cash equivalents, and restricted cash at beginning of period	11,473,676	17,186,323
Cash, cash equivalents, and restricted cash at end of period	7,279,334	10,630,229
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash
Cash and equivalents	6,634,037	8,970,324
Restricted cash	645,297	1,659,905
Total cash, cash equivalents, and restricted cash	7,279,334	10,630,229
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for interest	257,145	288,397
Cash paid during the period for income taxes, net of refunds	37,698	312,806
Supplemental Schedule of Non-Cash Investing and Financing Activities
Shares issued to pay notes payable	232,145	3,288,071
Shares issued in connection with note payable		700,400
Investment in right of use asset	$ 76,506	$ 317,187